Evidence map›Paper›PMID 24570389›Full record

ArticleAnnals of biomedical engineering2014

Oxygen-tension controlled matrices for enhanced osteogenic cell survival and performance.

A R Amini, S P Nukavarapu

Abstract read
In one paragraph

Article in Annals of biomedical engineering, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Smart Orthopedic Biomaterials and Implants.Current opinion in biomedical engineering · 2023
    Article
  6. Article
  7. Review
  8. Biomaterial-directed cell behavior for tissue engineering.Current opinion in biomedical engineering · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. From skeletal development to the creation of pluripotent stem cell-derived bone-forming progenitors.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2018
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Biomaterials for Bone Regenerative Engineering.Advanced healthcare materials · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

A R AminiInstitute for Regenerative Engineering, University of Connecticut Health Center, Farmington, CT, USA.
S P Nukavarapu

Funding

Enhanced Osteoinduction and Angioinduction via Polymer/CaO2 Bone Tissue EngineeriR21AR062771 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LAURENCIN, CATO T. · 2012 to 2013
$427k
Optimal Biodegradable Scaffolds and Progenitor Cells for Effective Bone RegeneratF30DE022477 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI AMINI, AMI R · 2011 to 2013
$121k
NIAMS NIH HHS AR062771NIDCR NIH HHS F30 DE022477NIDCR NIH HHS F30DE022477
6 · The paper itself

Abstract

The success of a clinically-applicable bone tissue engineering construct for large area bone defects depends on its ability to allow for homogeneous bone regeneration throughout the construct. Insufficient vascularization, and consequently inadequate oxygen tension, throughout constructs has been largely cited as the most significant obstacle facing successful bone regeneration in large area defects. The development of constructs that support bone and vessel-forming cell growth and function throughout the scaffold structure are desired for large-area bone defect repair. Here, we developed oxygen tension-controlled matrices that support more homogenous oxygen levels throughout the constructs. Specifically, we examined polylactic co-glycolic acid (PLGA) scaffolds with optimized pore distribution and the percent pore volumes, and demonstrated significantly decreased oxygen and pH gradient from the exterior of the construct to the interior after long-term cell culture in vitro. We confirmed the ability of these optimized constructs to support the cellular survival via live/dead assay. In addition, we examined their ability to support the maintenance of two clinically relevant progenitor cell populations for bone tissue engineering and vascularization, namely mesenchymal stem cells (MSCs) and endothelial progenitor cells (EPCs), and confirmed the expression of key bone and vascular markers via immunofluorescence.

Indexed as

Bone RegenerationOsteogenesisAnimalsCell SurvivalExtracellular MatrixLactic AcidMesenchymal Stem CellsOxygenPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPorosityRabbitsTissue ScaffoldsLactic AcidOxygenPolyglycolic AcidPolylactic Acid-Polyglycolic Acid Copolymer

Identifiers

PMID24570389
PMCPMC5512167

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.